ENTITY
Sino Biopharmaceutical

Sino Biopharmaceutical (1177 HK)

191
Analysis
Health CareHong Kong
Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.
more
Publication Icon
No publications yet
There aren’t any broker reports right now
Back to "All"
x